This is a retatrutide signal, not a cagrilintide one
Back Marso, SP, Daniels, GH, Brown-Frandsen, K, et al (28 July 2016) 'Liraglutide and cardiovascular outcomes in type 2 diabetes', New England Journal of Medicine , 375/4, 311-22
The clinical evidence does not support AOD-9604 as an effective standalone anti-obesity treatment
Consequently, researchers in endocrinology, metabolism, and drug testing rely on this compound as a dependable choice for ongoing lab work
No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately
Alex Tatem, a board-certified urologist and member of Rugiets Medical Advisory Board, will testify at this weeks FDA hearings